{"id":"https://openalex.org/W2332015145","doi":"https://doi.org/10.1158/1538-7445.am2013-1950","title":"Abstract 1950: Signature MicroRNAs involved In transition of androgen sensitive prostate cancer cells to androgen-insensitive ones during androgen deprivation therapy.","display_name":"Abstract 1950: Signature MicroRNAs involved In transition of androgen sensitive prostate cancer cells to androgen-insensitive ones during androgen deprivation therapy.","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W2332015145","doi":"https://doi.org/10.1158/1538-7445.am2013-1950","mag":"2332015145"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2013-1950","doi":"https://doi.org/10.1158/1538-7445.am2013-1950","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-1950","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015598370","display_name":"Richard Ottman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I106165777","display_name":"University of Central Florida","ror":"https://ror.org/036nfer12","country_code":"US","type":"education","lineage":["https://openalex.org/I106165777"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard J. Ottman","raw_affiliation_strings":["University of Central Florida, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Central Florida, Orlando, FL","institution_ids":["https://openalex.org/I106165777"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029749001","display_name":"Robert Lorch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I106165777","display_name":"University of Central Florida","ror":"https://ror.org/036nfer12","country_code":"US","type":"education","lineage":["https://openalex.org/I106165777"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Lorch","raw_affiliation_strings":["University of Central Florida, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Central Florida, Orlando, FL","institution_ids":["https://openalex.org/I106165777"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075123044","display_name":"Camha Nguyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I106165777","display_name":"University of Central Florida","ror":"https://ror.org/036nfer12","country_code":"US","type":"education","lineage":["https://openalex.org/I106165777"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Camha Nguyen","raw_affiliation_strings":["University of Central Florida, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Central Florida, Orlando, FL","institution_ids":["https://openalex.org/I106165777"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063795605","display_name":"Ratna Chakrabarti","orcid":"https://orcid.org/0000-0002-0261-8520","observed_orcids":["https://orcid.org/0000-0002-0261-8520"]},"institutions":[{"id":"https://openalex.org/I106165777","display_name":"University of Central Florida","ror":"https://ror.org/036nfer12","country_code":"US","type":"education","lineage":["https://openalex.org/I106165777"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ratna Chakrabarti","raw_affiliation_strings":["University of Central Florida, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Central Florida, Orlando, FL","institution_ids":["https://openalex.org/I106165777"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I106165777"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"8_Supplement","first_page":"1950","last_page":"1950"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8895999789237976,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8895999789237976,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.1071000024676323,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9020000100135803},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.9210000038146973},{"id":"https://openalex.org/keywords/microrna-expression-profiling","display_name":"miRNA expression profiling","score":0.7839999794960022},{"id":"https://openalex.org/keywords/androgen-receptor","display_name":"androgen receptor","score":0.5329999923706055},{"id":"https://openalex.org/keywords/lncap-cells","display_name":"LNCaP cells","score":0.9470000267028809},{"id":"https://openalex.org/keywords/mirna-target-prediction","display_name":"miRNA target prediction","score":0.7049999833106995},{"id":"https://openalex.org/keywords/transcription-factors","display_name":"transcription factors","score":0.7789999842643738},{"id":"https://openalex.org/keywords/pro-apoptotic-signaling","display_name":"pro-apoptotic signaling","score":0.8920000195503235},{"id":"https://openalex.org/keywords/oncoprotein","display_name":"oncoprotein","score":0.875},{"id":"https://openalex.org/keywords/mitogenic-signaling","display_name":"mitogenic signaling","score":0.7979999780654907},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.8669999837875366},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.9829999804496765},{"id":"https://openalex.org/keywords/prostate-cancer-progression","display_name":"prostate cancer progression","score":0.8090000152587891},{"id":"https://openalex.org/keywords/microrna-downregulation","display_name":"microRNA downregulation","score":0.4690000116825104}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.8783522844314575},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.8036905527114868},{"id":"https://openalex.org/C2779723316","wikidata":"https://www.wikidata.org/wiki/Q6459234","display_name":"LNCaP","level":4,"score":0.7363311648368835},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.6494817733764648},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.6222033500671387},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.6124445796012878},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5454344153404236},{"id":"https://openalex.org/C2781114028","wikidata":"https://www.wikidata.org/wiki/Q6746708","display_name":"Management of prostate cancer","level":4,"score":0.44836825132369995},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.443258672952652},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.439448744058609},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4310513138771057},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42116329073905945},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3850627541542053},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35561931133270264},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.1318320333957672},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.13110488653182983},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.058395832777023315}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2013-1950","doi":"https://doi.org/10.1158/1538-7445.am2013-1950","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-1950","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.47999998927116394}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2168428430","https://openalex.org/W2058568096","https://openalex.org/W2047155646","https://openalex.org/W2605285233","https://openalex.org/W2743518443","https://openalex.org/W2745295423","https://openalex.org/W4379143156","https://openalex.org/W2314955586","https://openalex.org/W2742031224","https://openalex.org/W4362595727"],"abstract_inverted_index":{"Abstract":[0],"Because":[1],"of":[2,29,36,43,55,66,74,85,93,101,118,122,144,152,168,176,190,257,286,305,328,339,351,363,383,399,404],"the":[3,11,27,64,72,116,141,147,174,186,241,267,306,325,336,340,349,400,405],"clinical":[4],"efficacy,":[5],"androgen":[6,19,23,30,67,77,123,163,384,393],"blockade":[7,20],"therapy":[8],"has":[9,88,103,129],"become":[10],"mainstay":[12],"for":[13,96,230,293,312,361,408],"advanced":[14,364],"prostate":[15,45,59,125,157,365,386],"cancer.":[16,366],"However,":[17,115],"prolonged":[18],"either":[21],"by":[22,26,277],"deprivation":[24,164,394],"or":[25,69,296],"use":[28],"receptor":[31],"antagonists,":[32],"leads":[33],"to":[34,63,76,112,127,162,221,389],"activation":[35],"various":[37],"adaptive":[38],"mechanisms,":[39],"which":[40,171],"promotes":[41],"development":[42,151,350],"hormone-refractory":[44],"cancer":[46,60,97,126,158,387],"(HRPC).":[47],"Microarray":[48],"analysis":[49,198,322],"revealed":[50],"an":[51],"increasingly":[52],"complex":[53],"profile":[54],"gene":[56,94],"expression":[57,95,100,142,189,209,219,326,337],"in":[58,91,120,140,173,208,299,317,333],"with":[61,106,245,266,335],"respect":[62],"status":[65],"sensitivity":[68],"refractoriness":[70],"but":[71],"process":[73],"progression":[75,121],"insensitivity":[78],"is":[79],"not":[80,130],"well":[81],"understood.":[82],"Recently,":[83],"role":[84,117],"MicroRNAs":[86,379],"(miRNA)":[87],"been":[89,104,131],"demonstrated":[90],"regulation":[92],"progression.":[98],"Aberrant":[99],"miRNAs":[102,119,145,192,212,227,236,259,279,341],"correlated":[105],"tumor":[107],"differentiation,":[108],"metastasis,":[109],"and":[110,188,210,233,250,271,314,353,358],"resistance":[111],"therapeutic":[113,359],"strategies.":[114],"sensitive":[124,155,385],"HRPC":[128,352],"clearly":[132],"defined.":[133],"In":[134,302,381],"this":[135],"study,":[136],"we":[137,252],"examined":[138],"changes":[139,244],"profiles":[143,327,338],"at":[146,181],"genome":[148],"level":[149],"during":[150,392],"HRPC.":[153],"Androgen":[154],"LNCaP":[156],"cells":[159,169,388],"were":[160,179,193,228,237,275,280,297],"subjected":[161],"until":[165],"a":[166],"subset":[167],"remained,":[170],"survived":[172],"absence":[175],"androgen.":[177],"Samples":[178],"collected":[180],"different":[182],"time":[183],"points":[184],"along":[185],"treatment":[187],"1,113":[191],"monitored":[194],"through":[195],"qRT-PCR.":[196],"Initial":[197],"identified":[199],"140":[200],"miRNas":[201],"that":[202,213,239,274,324],"had":[203,214],"more":[204,215],"than":[205,216],"three-fold":[206,217],"reduction":[207],"137":[211],"elevated":[218],"compared":[220],"untreated":[222],"samples.":[223],"Of":[224],"these,":[225],"100":[226],"selected":[229],"further":[231,281],"validation,":[232],"finally":[234],"41":[235],"chosen":[238],"displayed":[240],"most":[242],"significant":[243],"treatment.":[246],"Using":[247],"online":[248],"tools":[249],"databases":[251],"determined":[253],"potential":[254,356],"mRNA":[255],"targets":[256,265,360],"these":[258,287,329],"based":[260],"on":[261],"sequence":[262],"homology.":[263],"MRNA":[264],"highest":[268],"binding":[269],"scores":[270],"especially":[272],"those":[273],"targeted":[276],"multiple":[278],"investigated.":[282],"We":[283],"found":[284],"many":[285,304],"putatively":[288,307],"down":[289],"regulated":[290,309],"mRNAs":[291,310],"code":[292,311],"transcriptional":[294],"regulators":[295],"involved":[298,316,380],"pro-apoptotic":[300],"signaling.":[301,319],"contrast":[303],"up":[308],"oncoproteins":[313],"proteins":[315,330],"mitogenic":[318],"Western":[320],"blot":[321],"confirmed":[323],"are":[331],"indeed":[332],"correlation":[334],"identified.":[342],"Our":[343],"results":[344],"provide":[345],"important":[346],"insight":[347],"into":[348],"additionally,":[354],"identify":[355],"biomarkers":[357],"management":[362],"Citation":[367],"Format:":[368],"Richard":[369],"J.":[370],"Ottman,":[371],"Robert":[372],"Lorch,":[373],"Camha":[374],"Nguyen,":[375],"Ratna":[376],"Chakrabarti.":[377],"Signature":[378],"transition":[382],"androgen-insensitive":[390],"ones":[391],"therapy.":[395],"[abstract].":[396],"In:":[397],"Proceedings":[398],"104th":[401],"Annual":[402],"Meeting":[403],"American":[406],"Association":[407],"Cancer":[409,419],"Research;":[410],"2013":[411],"Apr":[412],"6-10;":[413],"Washington,":[414],"DC.":[415],"Philadelphia":[416],"(PA):":[417],"AACR;":[418],"Res":[420],"2013;73(8":[421],"Suppl):Abstract":[422],"nr":[423],"1950.":[424],"doi:10.1158/1538-7445.AM2013-1950":[425]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2016-06-24T00:00:00"}